Skip Nav Destination
Close
Article navigation
Correspondence|
August 1994
Is Aprotinin Worth the Risk in Total Hip Replacement?
Department of Anesthesiology Head of Autologous Blood Service; Department of Orthopedics; Associate Professor, Department of Orthopedics; Klinik für Anaesthesiologic und Operative Intensivmedizin der Universitat zu Köln Joseph-Stelzmann-Strase 9 D-50924 Koln, Germany
Anesthesiology August 1994, Vol. 81, 517.
Citation
Stefan-Mario Kasper, Joachim Schmidt, Jürgen Rütt; Is Aprotinin Worth the Risk in Total Hip Replacement?. Anesthesiology 1994; 81:517 doi: https://doi.org/10.1097/00000542-199408000-00038
Download citation file:
Close
Citing articles via
Most Viewed
Related Articles
Aprotinin Decreases Blood Loss and Homologous Transfusions in Patients Undergoing Major Orthopedic Surgery
Anesthesiology (January 1998)
Influence of High-dose Aprotinin on Anticoagulation, Heparin Requirement, and Celite- and Kaolin-Activated Clotting Time in Heparin-pretreated Patients Undergoing Open-Heart Surgery: A Double-blind, Placebo-controlled Study
Anesthesiology (October 1995)
Do Hospitals Performing Frequent Neuraxial Anesthesia for Hip and Knee Replacements Have Better Outcomes?
Anesthesiology (September 2018)
